InvestorsHub Logo
Followers 282
Posts 3478
Boards Moderated 1
Alias Born 07/04/2018

Re: None

Saturday, 08/17/2019 1:46:25 PM

Saturday, August 17, 2019 1:46:25 PM

Post# of 186029
Reminder: just prior to the revolving line of credit, VRUS arranged for $600K at just 4% interest backed by a convertible note --convertible any time at 10 cents per share. Combined with all the other developments, to me this means a price well above 10 cents per share is a realistic near-to-medium-term price target, since to make sufficient profits to justify undertaking the deal and ultimately converting the note, the lender would expect 10 cents pps to be a steep discount to market price in the foreseeable future. I'm just speculating here of course, but when you compare this financing to the kinds of toxic-death-spiral financing most OTCs get involved with, VRUS's financing is immeasurably better for the company and for shareholders. They're building something big here.

I doubled my position over the last month--still buying under .018 when the opportunity arises.

GLTA!